Ghazaleh Tabatabai

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Wolfgang Wick, Michael Platten, Christoph Meisner et al. · The Lancet Oncology · 2012 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Oncology +14

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 932 citations · Full text

Medicine, Biomedical Sciences, Oncology +12

EANO guideline on the diagnosis and management of meningiomas

Roland Goldbrunner, Pantelis Stavrinou, Michael D. Jenkinson et al. · Neuro-Oncology · 2021 · 707 citations · Full text

Medicine, Neurosurgery, Oncology +17

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 576 citations · Full text

Medicine, Oncology, Pharmacology +16

Glioma progression is shaped by genetic evolution and microenvironment interactions

Frederick S. Varn, Kevin C. Johnson, Jason T. Huse et al. · Cell · 2022 · 498 citations · Full text

Medicine, Cancer Biology, Oncology +16